Warning letter
Buffalo Pharmacies Inc. dba Swan Prescription Center: warning letter of Dec 13, 2017
FDA warning letter 539769 · New Jersey District Office
Key facts
| Reference number | 539769 |
|---|---|
| Company | Buffalo Pharmacies Inc. dba Swan Prescription Center |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Dec 13, 2017 |
| Posted date | Dec 13, 2017 |
| Issuing office | New Jersey District Office |
| Product type | Drugs |
| CFR sections cited | 200.10(b), 211.42(c)(10)(iii), 211.42(c)(10)(iv), 211.42(c)(10)(v), 211.113(b), 210.1(b) |
| Inspection city | East Amherst |
| Inspection ZIP | 14051-1803 |
| Inspection start date | Jun 20, 2017 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: